Spinal Muscular Atrophy (SMA) will be added to the routine heel prick newborn screening offered to babies in England, health officials have announced. The policy change means the same population already offered the newborn blood spot test will be offered screening for SMA so affected infants can be identified earlier and referred for follow-up care.
The announcement has prompted public responses, including from singer Jesy Nelson, who described the decision as a “victory” in coverage reported by BBC News. Below is a clear, sourced summary of what the change means, how the heel prick test works, expected next steps after a positive screen, practical advice for parents, and where to find official guidance.
What the change means for newborns
Under the expansion, all newborn babies in England will be routinely offered the heel prick (newborn blood spot) test that now includes a screen for Spinal Muscular Atrophy (SMA). The change integrates SMA into the existing screening offer rather than creating a separate pathway (BBC News: coverage of the policy announcement).
The NHS newborn blood spot test is normally offered in the first few days after birth, either before discharge from hospital or during an early community visit. If a screening result flags a possible abnormality, health teams contact families promptly to arrange confirmatory testing and specialist review (NHS guidance on newborn screening).
What is Spinal Muscular Atrophy (SMA)?
Spinal Muscular Atrophy (SMA) is a genetic condition that affects the nerves controlling voluntary muscles and can lead to progressive muscle weakness. Severity varies by type and by child. Early detection through newborn screening means some babies can be identified before symptoms appear, allowing clinical teams to arrange confirmatory tests, monitoring and discussions about treatment and support as early as possible (NHS: newborn screening information).
How the heel prick test works and next steps after a positive result
The heel prick test, also called the newborn blood spot test, involves taking a few drops of blood from a baby’s heel and placing them on a special card for laboratory testing. The sample is analysed for a panel of conditions; the updated panel in England will include a screening marker for SMA (NHS: newborn blood spot test).
A screening result that suggests SMA is not a diagnosis. A positive screen triggers urgent follow-up: parents are contacted and offered confirmatory testing, usually additional blood tests, and referral to a specialist paediatric neuromuscular or metabolic service. Clinical teams explain the meaning of the result, the timetable for confirmation and the options for monitoring and treatment (NHS newborn screening guidance).
If confirmatory testing shows a diagnosis of SMA, clinicians will discuss the local care pathway, which may include regular monitoring, therapies and access to support services. The specific follow-up steps and treatment availability can vary by location; clinicians and specialist teams will explain local arrangements to families (NHS).
Public reaction and quotes
The policy change has been welcomed by some campaigners and families who have sought wider access to newborn screening for SMA. Singer Jesy Nelson described the announcement as a “victory” in reporting by BBC News, reflecting relief among advocates who lobbied for the expansion (BBC News).
At the same time, commentators and some clinicians have noted that practical questions remain about rollout and local implementation — for example, how quickly results will be processed and how rapidly confirmatory testing and specialist appointments can be arranged in different areas (BBC News coverage and NHS comments on implementation).
What parents should know now
What parents should know is that the heel prick newborn screening offer in England will include SMA as part of the standard blood spot panel. If you are expecting or have recently had a baby, the following points are useful to discuss with your midwife or health visitor:
- When the heel prick test will be performed for your baby.
- Which conditions, including SMA, are included in the test panel.
- How and when results will be communicated and who will contact you if a screen is positive.
- What the confirmatory testing process involves and who will coordinate specialist follow-up.
Practical tips: keep your contact details up to date with the maternity team, ask for written information if helpful, and request clear timescales for when you might expect screening results. If a screen indicates a possible issue, health professionals should explain the finding, why confirmatory tests are needed and what local support and treatment options are available (NHS guidance).
Timeline: when will screening start?
The official announcement confirms plans to add SMA screening to the newborn blood spot programme in England, but reporting at the time of the announcement did not give a precise national start date for rollout. Local implementation timelines may vary while national programmes and NHS services put operational arrangements in place (BBC News). Parents should ask their local maternity service or health visitor for the latest local timetable and check the NHS newborn screening pages for updates.
FAQ
What is SMA and why does early screening help?
SMA is a genetic condition causing progressive weakness of voluntary muscles. Early screening can identify affected babies before symptoms appear, enabling quicker confirmatory testing, earlier clinical monitoring and earlier access to treatments and support that are most effective when started promptly (NHS newborn screening information).
When will the heel prick test start for all newborns in England?
The expansion has been announced, but a precise nationwide start date was not published alongside the announcement; implementation will follow national planning and local rollout. For the most accurate timetable, contact your local maternity unit or check NHS updates (BBC News; NHS).
What happens if a newborn tests positive for SMA?
A positive screening result leads to urgent confirmatory testing — usually further blood tests — and referral to specialist paediatric services. If a diagnosis is confirmed, the clinical team will explain monitoring, treatment options and support services available in your area (NHS).
Sources and further reading
- BBC News – Health: Coverage of the SMA newborn screening announcement
- NHS – Newborn screening: the blood spot (heel prick) test
- GOV.UK – Newborn blood spot screening programme information
For specific questions about timing and local arrangements, contact your maternity unit, midwife or health visitor. News coverage cited above includes quotes and reporting from public figures such as Jesy Nelson as reported by BBC News.
